Nonprofit buys experimental cancer drug to maintain patient access
In a rare move, nonprofit organization Blood Cancer United is buying the remaining supplies of a discontinued investigational cancer drug.
Read full article →Healthcare Policy
Latest Healthcare Policy news from across the web.
Study highlights influence of socioeconomic status on children’s brain development
A new study found that the number one environmental factor influencing brain structure and function is the socioeconomic status of a child's family.
Read full article →STAT+: Abridge inks deals with Nvidia and Lilly
Abridge announced new deals with Eli Lilly and Nvidia as it aims to gain an edge in a competitive market.
Read full article →Ebola testing has improved in DRC, but still isn't nearly enough
The DRC has improved testing capacity for Ebola, with two facilities operating in or near the epicenter. But this still may not be enough to keep up with a rapidly expanding disease.
Read full article →Socioeconomic factors are becoming 'biologically embedded' in children's brains
A study of more than 2,300 9- to 10-year-olds found that socioeconomic factors explained most differences in the preteens' brain development.
Read full article →White House response to hantavirus and Ebola contrasts with COVID criticisms
The administration imposed mandatory quarantine orders on two passengers from the cruise ship hit by hantavirus and is blocking Americans who catch Ebola from returning home for treatment.
Read full article →STAT+: A suspicious denial pattern in Medicare Advantage
Major Medicare Advantage plans almost always reversed their denials on appeal, raising big questions about barriers to care.
Read full article →STAT+: Novartis doubles down on molecular glue strategy
Seniors' drug costs rise sharply, Enliven's leukemia drugs, and more biotech news from The Readout
Read full article →STAT+: Pharmalittle: We’re reading about employer coverage of obesity drugs, another Sanofi setback, and more
More employers are planning to drop coverage of GLP-1 drugs for weight loss next year as increasing numbers of people take the medications
Read full article →STAT+: ‘Synthetic lethality’ could trigger another round of biotech M&A
Proving out a "synthetic lethality" approach can help treat cancer will take a lot more work. It also might trigger some creative deal-making.
Read full article →STAT+: Enliven Therapeutics’ leukemia drug shows promise in new study
A targeted drug from Enliven Therapeutics induced molecular responses in nearly half of patients with advanced leukemia, new data show.
Read full article →HHS responds coolly to paper on alcohol risk
Soda and liver cancer, scientists conflicted on a new NIH proposal, and more health news from Morning Rounds
Read full article →